Requiring the Maryland Department of Health to adopt certain regulations regarding the administration of mifepristone; requiring that mifepristone be provided by or under the supervision of a physician who meets certain qualifications and conditions; requiring each provider of mifepristone to make certain certifications and disclose certain information; establishing a certain penalty; requiring the Department to report to the General Assembly on or before December 1, 2019, and each December 1 thereafter; etc.
Bill File Type: Regular
Effective Date(s): October 1, 2019
( 21-228 )
Last Updated: 2/3/2020 2:31 PM